The state of dry, wet AMD in 2021

Video

Rishi P. Singh, MD, highlights various treatment options available for the management of patients with age-related macular degeneration, as well as the status of potential therapies.

See more AMD content here

Recent Videos
Related Content
International study illuminates economic burden of late-stage age-related macular degeneration

International study illuminates economic burden of late-stage age-related macular degeneration

Lynda Charters
April 1st 2025
Article
John Kitchens, MD, is joined by Peter Kaiser, MD, to discuss higher molar dose and its translation into clinical practice

Implementing Higher Molar Dose in Your Clinical Practice

John Kitchens, MD;Peter K. Kaiser, MD
July 24th 2024
Podcast
Opthea discontinues COAST and ShORe trials in wet AMD

Opthea discontinues COAST and ShORe trials in wet AMD

Martin David Harp
March 31st 2025
Article
Opthea phase 3 clinical trial, COAST, in patients with wet age-related macular degeneration fails to meet primary endpoint

Opthea phase 3 clinical trial, COAST, in patients with wet age-related macular degeneration fails to meet primary endpoint

Martin David Harp
March 25th 2025
Article
Aflibercept treat-and-extend regimen for neovascular AMD: 5-year outcomes

Aflibercept treat-and-extend regimen for neovascular AMD: 5-year outcomes

Lynda Charters
March 19th 2025
Article
The future of retina: New targets and more durable solutions

The future of retina: New targets and more durable solutions

Robin Vora, MD;Hannah El-Sabrout
March 18th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.